IOTR_OUT_1 [2025-04-16 10:08:59 -0400] 2355 Bytes | 597 tokens | Cum: 597 tkns (7.46% of 8k)
==========================================================================

You're the expert here today. So, I pulled together a bunch of data for you to look over real fast. I'm looking at high-performance stocks today and iOThree (IOTR) hit my radar screen, up to 5.8819 from a prev close of 4.0400 Do you think its got more juice or is it lacking potential? It's 10:08:58 AM on Wed Apr 16, 2025 -0400 and I have to decide: buy or sell!

--- COMPANY PROFILE ---
Company: iOThree (IOTR)
IPO: 2025-04-10 (6 Days Ago)
Market Cap: $129,532,500
Shares Outstanding: 25,650,000
Exchange: XNAS

Here’s a list of headlines for iOThree:

Apr-12-25 01:30AM - U.S. IPO Weekly Recap: Flurry Of Small Issuers List, Despite Heightened Market Volatility
Apr-11-25 04:00PM - iOThree Limited Announces Closing of Initial Public Offering
Apr-09-25 09:00PM - iOThree Limited Announces Pricing of Initial Public Offering

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2025-04-11T20:00:00Z - iOThree Limited Announces Closing of Initial Public Offering

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for iOThree (IOTR).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

IOTR_OUT_3 [2025-04-16 10:09:01 -0400] 845 Bytes | 214 tokens | Cum: 813 tkns (10.16% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**iOThree Limited Announces Closing of Initial Public Offering**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/04/11/3060305/0/en/iOThree-Limited-Announces-Closing-of-Initial-Public-Offering.htmliOThree Limited, a provider of maritime digital technologies, announced the closing of its initial public offering on the Nasdaq Capital Market under the ticker symbol 'IOTR'. The company raised $6.6 million and plans to use the proceeds for solution development, obtaining class approval, and marketing and branding.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

IOTR_OUT_5 [2025-04-16 10:09:03 -0400] 829 Bytes | 237 tokens | Cum: 1052 tkns (13.15% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-12T01:41:07Z - Opening Day: Masterbeef, Aether make trading debut...
A2 - 2025-04-11T20:00:45Z - iOThree Limited Announces Closing of Initial Public Offering...
A3 - 2025-04-11T20:00:45Z - iOThree Limited Announces Closing of Initial Public Offering...
A4 - 2025-04-11T20:19:48Z - iOThree Limited Announces Closing of Initial Public Offering...
A5 - 2025-04-11T20:10:25Z - iOThree Limited Announces Closing of Initial Public Offering...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

IOTR_OUT_7 [2025-04-16 10:09:05 -0400] 1181 Bytes | 310 tokens | Cum: 1364 tkns (17.05% of 8k)
==========================================================================

Showing A1 (chunk 1 of 7): A1:
**Opening Day: Masterbeef, Aether make trading debut**Date: 2025-04-12Source: {'uri': 'markets.businessinsider.com', 'dataType': 'news', 'title': 'Markets Insider'}URL: https://markets.businessinsider.com/news/stocks/opening-day-masterbeef-aether-make-trading-debut-1034576076Hong Kong restaurant group Masterbeef raised $8M in its IPO earlier this week. Shares of the investment research platform Aether also made their public debut on Thursday.

Masterbeef (MB) opened on April 10 at $3.80. The full-service restaurant group in Hong Kong specializing in Taiwanese hotpot and Taiwanese barbecue priced its initial public offering of 2M ordinary shares at a public offering price of $4.00 per ordinary share. The deal priced at the low end of its $4.00-$5.00 range.

Cuprina Holdings (CUPR) opened on April 10 at $4.40. The company priced its firm commitment initial public offering of an aggrega

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

IOTR_OUT_9 [2025-04-16 10:09:06 -0400] 1181 Bytes | 285 tokens | Cum: 1651 tkns (20.64% of 8k)
==========================================================================

Showing A1 (chunk 2 of 7): te 3M shares of its Class A ordinary shares, all of which are being offered by Cuprina at a public offering price of $4.00 per share. Cuprina is a biomedical and biotechnology company that says it is dedicated to the development and commercialization of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty sector.

Aether (ATHR) opened on April 10 at $5.25. The "emerging financial technology holding company offering software, data, and artificial intelligence technology to institutional and self-directed investors" priced its initial public offering of 1.8M shares of its common stock at a price to the public of $4.30 per share. The deal range was $4.00-$5.00.

iOThree (IOTR) opened on April 10 at $3.60. The provider of maritime digital technologies including satellite connectivity and digitalization solutions in Singapore with a focus on facili

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

IOTR_OUT_11 [2025-04-16 10:09:07 -0400] 1181 Bytes | 290 tokens | Cum: 1943 tkns (24.29% of 8k)
==========================================================================

Showing A1 (chunk 3 of 7): tating the maritime industry towards digital transformation priced its initial public offering of an aggregate of 2.1M ordinary shares at a public offering price of $4.00 per share, of which 1.65M ordinary shares are offered by the company and 450,000 ordinary shares are offered by the selling shareholders of the company. The deal size was reduced to 2.1M shares from 2.63M and priced at the low end of the $4.00-$6.00 range.

FatPipe (FATN) opened on April 8 at $6.50. The company priced 695,656 shares at $5.75 per share. FatPipe describes itself as "a pioneer in enterprise-class, application-aware, secure software-defined wide area network solutions for organizations, including enterprises, communication service providers, security service providers, government organizations, and middle-market companies."

Titan Acquisition (TACH) opened on April 9 at $9.99. The units are listed on the Na

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

IOTR_OUT_13 [2025-04-16 10:09:08 -0400] 1181 Bytes | 259 tokens | Cum: 2204 tkns (27.55% of 8k)
==========================================================================

Showing A1 (chunk 4 of 7): sdaq and trade under the ticker symbol "TACHU."

JiaLian Technologies has filed with the SEC for a planned initial public offering. The company has applied to list its Class A ordinary shares on the Nasdaq Global Market under the symbol "JLCN." The prospectus states, "We have built a cross-border fulfillment network optimized for large parcel products. Our operations span multiple locations in China, Kunming, Japan, and the United States. The U.S. remains our largest market, where we operate 21 large-scale warehouses totaling over four million square feet of storage space, covering 11 ports of destination with over ten thousand annual containers... We leverage our proprietary data and AI to accelerate network effects on our platform. As our marketplace grows, we accumulate valuable user and product data to develop analytical and predictive tools, such as product sales forecasts. This inf

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

IOTR_OUT_15 [2025-04-16 10:09:09 -0400] 1181 Bytes | 259 tokens | Cum: 2465 tkns (30.81% of 8k)
==========================================================================

Showing A1 (chunk 5 of 7): ormation helps sellers efficiently manage inventory and pricing strategies. Successful sellers attract more participants, expanding our product offerings. Our broad selection, competitive pricing, and virtual warehousing capabilities encourage buyers to join and transact, creating a virtuous cycle."

Circle, the second largest stablecoin issuer which filed confidentially in January 2024, has filed publicly for an initial public offering. The company is seeking to list on the New York Stock Exchange under the symbol "CRCL." The company's prospectus filed with SEC states, "As the Circle stablecoin network grows, we believe that our ability to monetize it will grow as well. Today, we monetize the amount of money on the network. We earn reserve income on USDC reserve assets, at rates at a discount to the prevailing SOFR. We believe that our current revenue model has been successful, with 202

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

IOTR_OUT_17 [2025-04-16 10:09:10 -0400] 1181 Bytes | 286 tokens | Cum: 2753 tkns (34.41% of 8k)
==========================================================================

Showing A1 (chunk 6 of 7): 4 revenue, net income, and Adjusted EBITDA of $1.7B, $156M, and $285M, respectively."

Happy City filed with the SEC for an initial public offering of 1M Class A ordinary shares of Happy City Holdings Limited, representing 14.29% of the Class A ordinary shares following completion of the offering. The company expects the initial public offering price will be between $5.00 and $7.00 per Class A share and notes it has reserved the symbol "HCHL" for purpose of listing its Class A ordinary shares on the Nasdaq Capital Market.

Odyssey Therapeutics has filed with the SEC for an initial public offering of shares of common stock. The company has applied to list its common stock on the Nasdaq Capital Market under the trading symbol "ODTX." The prospectus filed with the SEC states, "Odyssey is a clinical-stage biopharmaceutical company led by a team and board of drug hunters seeking to transform

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

IOTR_OUT_19 [2025-04-16 10:09:11 -0400] 999 Bytes | 249 tokens | Cum: 3004 tkns (37.55% of 8k)
==========================================================================

Showing A1 (chunk 7 of 7): the standard of care for patients suffering from autoimmune and inflammatory diseases... Our most advanced programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, for which we intend to commence a Phase 2a monotherapy trial for ulcerative colitis, or UC, in the first quarter of 2025 and a Phase 2a combination trial with vedolizumab in the first half of 2026, and two preclinical programs: a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains."

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

IOTR_OUT_21 [2025-04-16 10:09:13 -0400] 238 Bytes | 59 tokens | Cum: 3065 tkns (38.31% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

IOTR_OUT_23 [2025-04-16 10:09:14 -0400] 251 Bytes | 78 tokens | Cum: 3146 tkns (39.32% of 8k)
==========================================================================

You just read a chunk of S1.
You may now:
- Say "MOR" to continue this article
- Say "S2", "S3", etc. to request another
- Or say "NEX" to move to the next source

You are allowed up to 6 articles from this list. If you’re ready to move on, say NEX.

IOTR_OUT_25 [2025-04-16 10:09:20 -0400] 4738 Bytes | 1112 tokens | Cum: 4260 tkns (53.25% of 8k)
==========================================================================

This is our set of metrics for iOThree.
Please analyze the numbers.

+-------------------+----------------------+-----------------------+-------------------+
| Volume: 146,116 | Perf Month: - | Option/Short: No / No | Sales Y/Y TTM: - |
+-------------------+----------------------+-----------------------+-------------------+
| Avg Volume: 1.13M | Perf Quarter: - | Short Float: - | ROE: - |
+-------------------+----------------------+-----------------------+-------------------+
| Rel Volume: 1.22 | Index: - | Short Ratio: - | ROI: - |
+-------------------+----------------------+-----------------------+-------------------+
| RSI (14): - | Market Cap: 126.45M | Short Interest: - | Sales Surprise: - |
+-------------------+----------------------+-----------------------+-------------------+
| ATR (14): 0.97 | Shs Outstand: 25.65M | Beta: - | EPS Surprise: - |
+-------------------+----------------------+-----------------------+-------------------+
| SMA20: 23.13% | Shs Float: - | Sales Q/Q: - | P/E: - |
+-------------------+----------------------+-----------------------+-------------------+
| SMA50: 23.13% | Inst Own: - | Sales past 5Y: - | Earnings: - |
+-------------------+----------------------+-----------------------+-------------------+
| SMA200: 23.13% | Insider Own: - | Employees: 26 | |
+-------------------+----------------------+-----------------------+-------------------+
| Perf Week: - | Insider Trans: - | Debt/Eq: - | |
+-------------------+----------------------+-----------------------+-------------------+

The next section covers any insider trading by iOThree officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 5.87
Average Volume: 953627.4
30-Day High: 5.87
30-Day Low: 3.39
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of iOThree (IOTR).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about iOThree.

2) MARKET_SCORE[]
This conversation was initiated because IOTR is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for IOTR.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, IOTR could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect IOTR to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of iOThree.

11) ETHICAL_RATING[]
Rate iOThree’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of iOThree.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

IOTR_IN_27 [2025-04-16 10:09:21 -0400] 126 Bytes | 29 tokens | Cum: 4506 tkns (56.33% of 8k)
==========================================================================

====================================
[2025-04-16 10:09:21] # Analysis Completed
Elapsed Time: 23.03 seconds